Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-004445-42Phase 4Active
Phase 4, open-label, single-arm trial of ceftriaxone in osteomyelitis (OM), sponsored by Institute of Pharmacology and Toxicology. Primary endpoints: Bone and plasma pharmacokinetics of ceftriaxone and Criteria for development of improved prophylactic antibiotics. Started Dec 2006; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-004445-42.